2023 Form 5500 filing — New England Biolabs, Inc. 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20251027075614NAL0005300547001) for New England Biolabs, Inc. 401(K) Plan, reported by New England Biolabs, Inc. under EIN 04-2631963 and plan number 004. It reports 614 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20251027075614NAL0005300547001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- New England Biolabs, Inc.
- EIN
- 04-2631963
- Plan number
- 004
- Location
- Ipswich, MA
- Participants
- 614
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $139,192,292
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $139,192,292
- Employer contributions
- $4,317,067
- Participant contributions
- $7,361,200
- Total income / additions
- $43,235,177
- Benefits paid
- $45,400,353
- Administrative expenses
- $141,155
- Total expenses
- $46,117,026
- Net increase / (decrease)
- -$2,881,849
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Principal Life Insurance Company | CONTRACT ADMINISTRATOR | $140,080 | $600 |
| Morgan Stanley | INVESTMENT ADVISORY | $0 | $60,000 |
| Caron & Bletzer | ACCOUNTANT | $0 | $12,000 |